Señales en vivo de KA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 16:00):

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners...

Stats
Volumen de hoy	292 533
Volumen promedio	392 022
Capitalización de mercado	7.09M
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $-0.210 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.490
ATR14	$0.00700 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Bartoszek Raymond J.	Buy	903 995	Common Stock
2024-04-14	Iadonato Shawn	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Philips Craig W.	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Baker Keith	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Guillaudeux Thierry	Buy	225 000	Stock Option (Right to Buy)

INSIDER POWER
95.43
Last 64 transactions
Buy: 2 929 101 \| Sell: 94 301

Volumen Correlación

Largo: 0.04 (neutral)

Corto: -0.58 (weak negative)

Signal:(49.554) Neutral

Kineta, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kineta, Inc. Correlación - Moneda/Commodity

0.62
( weak )

0.76
( moderate )

0.00
( neutral )

0.70
( moderate )

-0.73
( moderate negative )

-0.07
( neutral )

Kineta, Inc. Finanzas

Annual	2023
Ingresos:	$5.44M
Beneficio Bruto:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2023
Ingresos:	$5.44M
Beneficio Bruto:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2022
Ingresos:	$1.95M
Beneficio Bruto:	$1.22M (62.42 %)
EPS:	$-12.80

FY	2021
Ingresos:	$9.09M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.152

Financial Reports:

No articles found.

Kineta, Inc.

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.